RT Tech Dev Notes (@techdevnotes)Grok Android App has crossed 50M+ downloads on Play Store! 🎉 https://t.co/yxCjZTN7o1 ...

In 2015, Mylan made a $29 billion unsolicited bid to acquire Perrigo (NYSE: PRGO ). This offer was later raised to a whopping $34 billion, and yet Perrigo, under then-CEO Joseph Papa, rejected the bid, claiming it “About the TPT serviceThanks for reading. At the Total Pharma Tracker, we offer the following:-Our Android app and website features a set of tools for DIY investors, including a work-in-progress software where you can enter any ticker and get extensive curated research material. For investors requ ...

Recently, I got a complaint from a frustrated reader who pointed out that since my bullish December coverage of Ideaya Biosciences, Inc. (NASDAQ: IDYA ), the stock has gone down relentlessly and is now down ~50%. A numberAbout the TPT serviceThanks for reading. At the Total Pharma Tracker, we offer the following:-Our Android app and website features a set of tools for DIY investors, including a work-in-progress software where you can enter any ticker and get extensive curated research material. For investor ...

I used to cover MeiraGTx (NASDAQ: MGTX ) a few years ago, but haven’t looked at it since 2022. MGTX develops genetic therapies for ocular diseases, Parkinson’s Disease and xerostomia. Lead asset is AAV-AQP1 targeting Xerostomia in a pivotal phase 2About the TPT ServiceThanks for reading. At the Total Pharma Tracker, we offer the following:-Our Android app and website features a set of tools for DIY investors, including a work-in-progress software where you can enter any ticker and get extensive curated rese ...